Ignite Creation Date:
2024-05-05 @ 7:18 PM
Last Modification Date:
2024-10-26 @ 9:46 AM
Study NCT ID:
NCT00640926
Status:
COMPLETED
Last Update Posted:
2016-05-12
First Post:
2008-03-18
Brief Title:
Safety and Efficacy Study of Oxazolidinone to Treat Pneumonia
Sponsor:
Melinta Therapeutics Inc
Organization:
Melinta Therapeutics Inc
Study Overview
Official Title:
A Phase 2 Multicenter Randomized Double-Blind Study to Evaluate the Safety and Efficacy of RX-1741 in the Treatment of Adult Patients With Mild to Moderate Severity of Community-Acquired Pneumonia CAP
Status:
COMPLETED
Status Verified Date:
2016-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether RX-1741 an oxazolidinone antibiotic is safe and effective in the treatment of mild to moderate community acquired pneumonia CAP
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None